---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-024401"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2023-07-13T23:59:59+00:00"
generated_at: "2026-06-13T09:16:16.111449+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oncotelic closes $1.0M debt-to-equity conversion; issues 40 Units with notes and warrants

## Summary
- Converted $1.0M of debt via private placement of 40 Units to accredited investors.
- Each Unit: $25K convertible note (16% interest, 2-yr, $0.10 conversion) and 250K warrants at $0.12/share.
- Total offering up to 200 Units ($5M); placement agent JH Darbie, $150K fees paid.
- Securities unregistered, exempt under Rule 506(b); Registration Rights Agreement filed.

## SEC filing metadata
- accession: 0001493152-23-024401
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2023-07-13T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315223024401/0001493152-23-024401-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315223024401/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-024401
- JSON: https://secwatch.observer/filing/0001493152-23-024401.json
- Plain text: https://secwatch.observer/filing/0001493152-23-024401.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.